Building on these results, a phase 1b trial in individuals with T2D further evaluated the safety, pharmacokinetics, and pharmacodynamics of once-weekly retatrutide over 12 weeks [43]
The most common side effects are gastrointestinal symptoms including nausea, vomiting, diarrhoea, and constipation, which are typically mild to moderate and improve with dose titration
Whats more, this platform is very budget-friendly as far as GLP-1 providers go
doi: 10.1016/j.kint.2023.09.029
The inclusion of oral GLP-1s at $149/month could make these medications even more accessible for patients who prefer a pill over injections
Thats why people have to take it on an empty stomach with just a sip of water, then wait 30 minutes before eating